ℹ️
🇬🇧
Search
Search for people relevant for "Anti-Cd20 Antibody"
Anti-Cd20 Antibody
Person
Class
Person
Publication
Programmes
MUDr. Pavel Vodárek Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
19 publications
Publications
publication
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group
2020 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Treatment of elderly and comorbid patients with chronic lymphocytic leukemia
2017 |
Faculty of Medicine in Hradec Králové
publication
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
2023 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
2023 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia
2023 |
Faculty of Medicine in Hradec Králové
publication
Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia
2022 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Chylothorax treatment with thoracic duct embolization
2022 |
Faculty of Medicine in Hradec Králové
publication
External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score
2021 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia
2021 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?
2021 |
Faculty of Medicine in Hradec Králové
Load more publications (9)
Loading network view...